GeneSegues gets gov’t contract to develop a topical vaccine for Venezuelan encephalitis
Minneapolis vaccine developer GeneSegues Therapeutics has a new government contract to develop a DNA vaccine against Venezuelan equine encephalitis virus – an infectious disease that has the potential to be used as a bioweapon, the feds say. It just received a $550,000 contract from the U.S. Defense Threat Reduction Agency to work with the U.S. Army Medical […]